CMS is moving forward with its proposals to address unlawful payment reductions to 340B drug reimbursement, according to a final rule released November 2. The final rule keeps most of the provisions of the proposed rule intact with only a few adjustments based on commenter feedback.
HHS released a proposed rule on October 27 regarding the federal independent dispute resolution (IDR) process for the No Surprises Act. The rule focuses on early communication between payers and providers, the open negotiation period, batching, eligibility, administrative fee structure, and registration.
The Office of Inspector General (OIG) recently conducted an audit to determine the financial impacts of expanding CMS’ hospital transfer policy for discharges to post-acute care to include all MS-DRGs.
CMS recently updated the national payment allowance and provided billing instructions for the new Novavax COVID-19 vaccine, authorized for patients 12 years and older.
CMS recently revised its instructions for new place of service (POS) code 27, which is used to report services provided to unsheltered homeless individuals.
Revenue integrity experts, we’re looking for you! NAHRI is currently accepting applications to present at the 2024 Revenue Integrity Symposium (RIS), to be held September 12–13 in Oak Brook, Illinois.
We are announcing that NAHRI and our parent company HCPro have been acquired from Simplify Compliance by AHIMA. While we see great synergies with AHIMA’s mission, HCPro, and its associated brands including NAHRI, will operate as a wholly owned subsidiary and will remain committed to serving as the premier healthcare community for revenue integrity professionals.
The American Medical Association (AMA) recently approved the consolidation of more than 50 codes used to report COVID-19 vaccines, as well as the addition of several new codes.
Revenue integrity professionals traveled from across the nation to Charlotte, North Carolina, to attend the 2023 Revenue Integrity Symposium (RIS), held September 18-19.